carboxyethylphosphoramide mustard

The dose-limiting toxic effect of cyclophosphamide (CY) is cardiotoxicity. The pathogenesis of myocardial damage is poorly… (More)

This study describes for the first time a method for the sequential analysis of the enantiomers of cyclophosphamide (CY) and its… (More)

A rapid and selective method for simultaneous determination of cyclophosphamide and its metabolite carboxyethylphosphoramide… (More)

This study investigates the efficacy and safety of personalized cyclophosphamide (CY) dosing in 50 patients receiving CY along… (More)

Cyclophosphamide-based regimens are front-line treatment for numerous pediatric malignancies; however, current dosing methods… (More)

PURPOSE Dose-related toxicity of cyclophosphamide may be reduced and therapeutic efficacy may be improved by pharmacokinetic… (More)

A method is described for the quantification of two metabolites of cyclophosphamide, specifically 4-hydroxycyclophosphamide (HCy… (More)

Although limited data are available about cyclophosphamide disposition in patients with renal insufficiency, nothing has been… (More)

It has been reported that the toxicity of carmustine (BCNU) cyclophosphamide (CY)/etoposide regimen (when BCNU is split into 4… (More)